|
|
|
|
LEADER |
00000cam a2200000Mi 4500 |
001 |
EBOOKCENTRAL_ocn923284553 |
003 |
OCoLC |
005 |
20240329122006.0 |
006 |
m o d |
007 |
cr |n||||||||| |
008 |
151010s2011 dcu ob 000 0 eng d |
040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d OCLCQ
|d MERUC
|d OCLCQ
|d LIP
|d OCLCF
|d ZCU
|d OCLCO
|d OCLCA
|d U3W
|d OCLCA
|d OCLCQ
|d OCLCO
|d OCLCQ
|d UUM
|d DKC
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCA
|d OCLCO
|d SFB
|d OCLCQ
|d OCL
|d OCLCO
|d OCLCL
|
019 |
|
|
|a 990616594
|
020 |
|
|
|a 9780309219303
|
020 |
|
|
|a 0309219302
|
020 |
|
|
|a 0309219299
|
020 |
|
|
|a 9780309219297
|
020 |
|
|
|a 1283311968
|
020 |
|
|
|a 9781283311960
|
020 |
|
|
|a 9786613311962
|
020 |
|
|
|a 6613311960
|
035 |
|
|
|a (OCoLC)923284553
|z (OCoLC)990616594
|
043 |
|
|
|a n-us---
|a n------
|
050 |
|
4 |
|a R853.C55.P83 2011eb
|
082 |
0 |
4 |
|a 610.724
|
049 |
|
|
|a UAMI
|
100 |
1 |
|
|a Weisfeld, Victoria.
|
245 |
1 |
0 |
|a Public Engagement and Clinical Trials :
|b New Models and Disruptive Technologies: Workshop Summary.
|
260 |
|
|
|a Washington :
|b National Academies Press,
|c 2011.
|
300 |
|
|
|a 1 online resource (117 pages)
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
588 |
0 |
|
|a Print version record.
|
505 |
0 |
|
|a FrontMatter -- Reviewers -- Contents -- Table, Figure, and Boxes -- Acronyms -- 1 Introduction -- 2 Framing the Problem -- 3 Recruitment Challenges in Clinical Trials for Different Diseases and Conditions -- 4 Models for Public Engagement -- 5 Messages and Methods for Public Engagement -- 6 The Media -- 7 Novel Clinical Trial Designs -- 8 The Health System�s Structure and Culture -- 9 Toward a Patient-Centered Strategy for Clinical Trials -- References -- Appendix A: Workshop Agenda -- Appendix B: The Clinical Trials Process
|
500 |
|
|
|a ""Appendix C: Participant Biographies""
|
546 |
|
|
|a English.
|
504 |
|
|
|a Includes bibliographical references.
|
520 |
|
|
|a Clinical trials provide essential information needed to turn basic medical research findings into patient treatments. New treatments must be studied in large numbers of humans to find out whether they are effective and to assess any harm that may arise from treatment. There is growing recognition among many stakeholders that the U.S. clinical trials enterprise is unable to keep pace with the national demand for research results. The IOM, along with the Mount Sinai School of Medicine, held a workshop June 27-28, 2011, to engage stakeholders and experts in a discussion about possible solutions to improve public engagement in clinical trials.
|
590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
650 |
|
0 |
|a Clinical trials
|z United States
|v Congresses.
|
650 |
|
0 |
|a Public health.
|
650 |
|
0 |
|a Medical care.
|
651 |
|
0 |
|a North America.
|
650 |
|
2 |
|a Evaluation Studies as Topic
|
650 |
|
2 |
|a Epidemiologic Study Characteristics as Topic
|
650 |
|
2 |
|a Publication Formats
|
650 |
|
2 |
|a Health Care Evaluation Mechanisms
|
650 |
|
2 |
|a Investigative Techniques
|
650 |
|
2 |
|a Americas
|
650 |
|
2 |
|a Epidemiologic Methods
|
650 |
|
2 |
|a Publication Characteristics
|
650 |
|
2 |
|a Analytical, Diagnostic and Therapeutic Techniques and Equipment
|
650 |
|
2 |
|a Public Health
|
650 |
|
2 |
|a Geographic Locations
|
650 |
|
2 |
|a Quality of Health Care
|
650 |
|
2 |
|a Health Care Quality, Access, and Evaluation
|
650 |
|
2 |
|a Geographicals
|
650 |
|
2 |
|a Environment and Public Health
|
650 |
|
2 |
|a Delivery of Health Care
|
650 |
|
2 |
|a Clinical Trials as Topic
|
650 |
|
2 |
|a Congresses
|
651 |
|
2 |
|a North America
|
651 |
|
2 |
|a United States
|
650 |
|
2 |
|a Patient Care
|
650 |
|
6 |
|a Études cliniques
|z États-Unis
|v Congrès.
|
650 |
|
6 |
|a Santé publique.
|
650 |
|
6 |
|a Prestation de soins.
|
651 |
|
6 |
|a Amérique du Nord.
|
650 |
|
6 |
|a Soins médicaux.
|
650 |
|
7 |
|a public health.
|2 aat
|
650 |
|
7 |
|a Public health
|2 fast
|
650 |
|
7 |
|a Medical care
|2 fast
|
650 |
|
7 |
|a Clinical trials
|2 fast
|
651 |
|
7 |
|a North America
|2 fast
|1 https://id.oclc.org/worldcat/entity/E39PBJxRHKPqWyj6g89H9PwHmd
|
651 |
|
7 |
|a United States
|2 fast
|1 https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq
|
655 |
|
7 |
|a Conference papers and proceedings
|2 fast
|
700 |
1 |
|
|a English, Rebecca.
|
758 |
|
|
|i has work:
|a Public engagement and clinical trials (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCFPdghJFG9MDDtWV4ytqHy
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
776 |
0 |
8 |
|i Print version:
|a Weisfeld, Victoria.
|t Public Engagement and Clinical Trials : New Models and Disruptive Technologies: Workshop Summary.
|d Washington : National Academies Press, ©1900
|z 9780309219297
|
856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=3378890
|z Texto completo
|
938 |
|
|
|a EBL - Ebook Library
|b EBLB
|n EBL3378890
|
994 |
|
|
|a 92
|b IZTAP
|